Regional aerobic glycolysis in the human brain

Department of Radiology, Washington University, St. Louis, MO 63110, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 10/2010; 107(41):17757-62. DOI: 10.1073/pnas.1010459107
Source: PubMed


Aerobic glycolysis is defined as glucose utilization in excess of that used for oxidative phosphorylation despite sufficient oxygen to completely metabolize glucose to carbon dioxide and water. Aerobic glycolysis is present in the normal human brain at rest and increases locally during increased neuronal activity; yet its many biological functions have received scant attention because of a prevailing energy-centric focus on the role of glucose as substrate for oxidative phosphorylation. As an initial step in redressing this neglect, we measured the regional distribution of aerobic glycolysis with positron emission tomography in 33 neurologically normal young adults at rest. We show that the distribution of aerobic glycolysis in the brain is differentially present in previously well-described functional areas. In particular, aerobic glycolysis is significantly elevated in medial and lateral parietal and prefrontal cortices. In contrast, the cerebellum and medial temporal lobes have levels of aerobic glycolysis significantly below the brain mean. The levels of aerobic glycolysis are not strictly related to the levels of brain energy metabolism. For example, sensory cortices exhibit high metabolic rates for glucose and oxygen consumption but low rates of aerobic glycolysis. These striking regional variations in aerobic glycolysis in the normal human brain provide an opportunity to explore how brain systems differentially use the diverse cell biology of glucose in support of their functional specializations in health and disease.

25 Reads
  • Source
    • " aerobic glycolysis under conditions of increased BACE1 activity mirrors early and predictive changes occurring in the brains of people who later develop AD . The brain areas that display this profile overlap with regions showing the greatest prevalence of Aβ pathology , future susceptibility to cell death and are predictive of cognitive decline ( Vaishnavi et al . , 2010 ; Vlassenko et al . , 2010 ) . The mechanisms underlying glucose hypometabolism in AD are not well - understood . However , mitochondrial dysfunction has been widely reported in clinical and experimental AD studies ( Lustbader et al . , 2004 ; Beal , 2005 ; Bubber et al . , 2005 ) and Aβ has been reported to accumulate in the mitochondr"
    [Show abstract] [Hide abstract]
    ABSTRACT: Glucose hypometabolism and impaired mitochondrial function in neurons have been suggested to play early and perhaps causative roles in Alzheimer's disease (AD) pathogenesis. Activity of the aspartic acid protease, beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1), responsible for beta amyloid peptide generation, has recently been demonstrated to modify glucose metabolism. We therefore examined, using a human neuroblastoma (SH-SY5Y) cell line, whether increased BACE1 activity is responsible for a reduction in cellular glucose metabolism. Overexpression of active BACE1, but not a protease-dead mutant BACE1, protein in SH-SY5Y cells reduced glucose oxidation and the basal oxygen consumption rate, which was associated with a compensatory increase in glycolysis. Increased BACE1 activity had no effect on the mitochondrial electron transfer process but was found to diminish substrate delivery to the mitochondria by inhibition of key mitochondrial decarboxylation reaction enzymes. This BACE1 activity-dependent deficit in glucose oxidation was alleviated by the presence of beta hydroxybutyrate or α-lipoic acid. Consequently our data indicate that raised cellular BACE1 activity drives reduced glucose oxidation in a human neuronal cell line through impairments in the activity of specific tricarboxylic acid cycle enzymes. Because this bioenergetic deficit is recoverable by neutraceutical compounds we suggest that such agents, perhaps in conjunction with BACE1 inhibitors, may be an effective therapeutic strategy in the early-stage management or treatment of AD.
    Frontiers in Cellular Neuroscience 10/2015; DOI:10.3389/fncel.2015.00382 · 4.29 Impact Factor
    • "This concept has been introduced following earlier observations that simple procedures, such as handling of rats or tail pinching, increases lactate release in brain (Kuhr and Korf 1988; De Bruin et al. 1990). Numerous further studies demonstrated that lactate formation from pyruvate is a regular process which takes place also in aerobic glycolysis (Brooks 2009; Vaishnavi et al. 2010). The source of lactate in this situation – neurons or glial cells – is unclear. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The lithium-pilocarpine model of status epilepticus is a well-known animal model of temporal lobe epilepsy. We combined this model with in vivo-microdialysis to investigate energy metabolites and acute cellular membrane damage during seizure development. Rats were implanted with dialysis probes and pretreated with lithium chloride (127 mg/kg i.p.). 24 hours later, they received pilocarpine (30 mg/kg s.c.) which initiated seizures within 30 min. In the dialysate from rat hippocampus, we observed a transient increase of glucose and a prominent, five-fold increase of lactate during seizures. Lactate release was due to neuronal activation because it was strongly reduced by infusion of tetrodotoxin, administration of atropine, or when seizures were terminated by diazepam or ketamine. In ex vivo-assays, mitochondrial function as measured by respirometry was not affected by 90 minutes of seizures. Extracellular levels of choline, however, increased twofold, and glycerol levels ten-fold, which indicates cellular phospholipid breakdown during seizures. Within 60 min of pilocarpine administration, hydroxylation of salicylate increased two-fold, and formation of isoprostanes twenty-fold, revealing significant oxidative stress in hippocampal tissue. Increases of lactate, glycerol and isoprostanes were abrogated, and increases of choline completely prevented, when hippocampal probes were perfused with calcium-free solution. Similarly, administration of pregabalin (100 mg/kg i.p.), a calcium channel ligand, 15 min prior to pilocarpine strongly attenuated parameters of membrane damage and oxidative stress. We conclude that seizure development in a rat model of status epilepticus is accompanied by increases of extracellular lactate, choline and glycerol, and by oxidative stress, while mitochondrial function remains normal for at least 90 minutes. Membrane damage depends on calcium influx and can be prevented by treatment with pregabalin. This article is protected by copyright. All rights reserved.
    Journal of Neurochemistry 09/2015; DOI:10.1111/jnc.13360 · 4.28 Impact Factor
    • "Energy expended to support neurons in the cerebral GM is analogous to the energy that powers computers in a network , whereas the energy consumed by WM is analogous to the energy expended for signal transmission and network infrastructure. Using this analogy, support of the normal WM connectivity takes as much energy as the support of the " computational nodes " [Harris and Attwell, 2012; Lee et al., 2012; Vaishnavi et al., 2010]. Evolution drove the structure and physiology of cerebral WM to maximize efficiency of information processing [Hildebrand et al., 1993; Laughlin and Sejnowski, 2003; Wen and Chklovskii, 2005]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reduced speed of cerebral information processing is a cognitive deficit associated with schizophrenia. Normal information processing speed (PS) requires intact white matter (WM) physiology to support information transfer. In a cohort of 107 subjects (47/60 patients/controls), we demonstrate that PS deficits in schizophrenia patients are explained by reduced WM integrity, which is measured using diffusion tensor imaging, mediated by the mismatch in WM/gray matter blood perfusion, and measured using arterial spin labeling. Our findings are specific to PS, and testing this hypothesis for patient-control differences in working memory produces no explanation. We demonstrate that PS deficits in schizophrenia can be explained by neurophysiological alterations in cerebral WM. Whether the disproportionately low WM integrity in schizophrenia is due to illness or secondary due to this disorder deserves further examination. Hum Brain Mapp, 2015. © 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.
    Human Brain Mapping 06/2015; 36(10). DOI:10.1002/hbm.22878 · 5.97 Impact Factor
Show more

Similar Publications


25 Reads
Available from